Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma
NCT00844688Phase 2Unknown
- Sponsor
- Combined Military Hospital
- Start
- Sep 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, gemcitabine in hepatocellular carcinoma (HCC), sponsored by Combined Military Hospital. Status: unknown.
02
Drugs
sorafenibgemcitabine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00844688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844688.